Aisling Capital as of March 31, 2018
Portfolio Holdings for Aisling Capital
Aisling Capital holds 10 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 70.7 | $397M | 3.4M | 115.37 | |
| Aimmune Therapeutics | 12.7 | $71M | 2.2M | 31.83 | |
| Viewray (VRAYQ) | 8.6 | $48M | 7.5M | 6.43 | |
| Transenterix | 3.0 | $17M | 9.9M | 1.70 | |
| Adma Biologics (ADMA) | 3.0 | $17M | 3.6M | 4.60 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.7 | $4.1M | 1.0M | 4.00 | |
| Agile Therapeutics | 0.6 | $3.4M | 1.3M | 2.57 | |
| Chimerix (CMRX) | 0.4 | $2.5M | 473k | 5.20 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $1.2M | 2.5M | 0.46 | |
| Pernix Therapeutics Holdings | 0.1 | $502k | 210k | 2.39 |
